
BRIACELL THERAPEUTICS CORP
BCTX · NASDAQ
Updated at 2026-11-16 21:33:13
- Today's High
- $3.44
- Today’s Low
- $3.28
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.45
- Previous Close
- $3.39
- Volume
- 25.19K
- Market Cap
- $29.6M
- P/E Ratio
- --
- EPS
- $-17.14
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- BELLEVUE CENTRE, WEST VANCOUVER, BC, CANADA, V7T 2X1
- Country
- CA
- Listing Date
- 2006-10-12
- Fiscal Year End
- July
- Shares Outstanding
- 8.7M
- CIK
- 0001610820
- Website
- briacell.com
BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada.
Financial Metrics
Revenue
2026-07-31
$0
2026-04-30
$0
2026-01-31
$0
2025-10-31
$0
Operating Expenses
2026-07-31
$12.57M
2026-04-30
$7.62M
2026-01-31
$7.64M
2025-10-31
$8.32M
Net Income
2026-07-31
-$12.32M
2026-04-30
-$7.16M
2026-01-31
-$7.35M
2025-10-31
-$8.19M
Net Profit Margin
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
--
Earnings Per Share
2026-07-31
$-1.24
2026-04-30
$-0.98
2026-01-31
$-2.57
2025-10-31
$-4.35
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-07-31
-$12.48M
2026-04-30
-$7.17M
2026-01-31
-$7.64M
2025-10-31
-$8.3M
Effective Tax Rate
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
--
| Item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $12.57M | $7.62M | $7.64M | $8.32M |
| Net Income | -$12.32M | -$7.16M | -$7.35M | -$8.19M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.24 | $-0.98 | $-2.57 | $-4.35 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$12.48M | -$7.17M | -$7.64M | -$8.3M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.